Prof. Dr. Pablo Fernandez-Peñas

Department of Dermatology, Westmead Hospital, The University of Sydney, Sydney, Australia

Prof. Dr. Pablo Fernandez-Peñas

Department of Dermatology, Westmead Hospital, The University of Sydney, Sydney, Australia

Co-authors

Following

Followers

Research Focus & Metrics

Explore full metrics on Scilit

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 March 2008 in Journal of the American Academy of Dermatology

Journal Article

Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features

Michelle Heath

Natalia Jaimes

Bianca Lemos

Arash Mostaghimi

Linda C. Wang

Peter P. Nghiem

1 August 2020 in Journal of Instrumentation

Journal Article

Volume I. Introduction to DUNE

B. Abi

R. Acciarri

G. Adamov

D. Adams

M. Adinolfi

R. Zwaska

+952

22 October 2015 in New England Journal of Medicine

Journal Article

A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention

Andrew C. Chen

Andrew J. Martin

Bonita Choy

Pablo Fernandez-Peñas

Robyn A. Dalziell

Diona L. Damian

Nonmelanoma skin cancers, such as basal-cell carcinoma and squamous-cell carcinoma, are common cancers that are caused principally by ultraviolet (UV) radiation. Nicotinamide (vitamin B₃) has been shown to have protective effects against damage caused by UV radiation and to reduce the rate of new premalignant actinic keratoses.

20 September 2016 in Physical Review D

Journal Article

Solar neutrino measurements in Super-Kamiokande-IV

K. Abe

Y. Haga

Y. Hayato

M. Ikeda

K. Iyogi

Super-Kamiokande Collaboration

+164

Upgraded electronics, improved water system dynamics, better calibration and analysis techniques allowed Super-Kamiokande-IV to clearly observe very low-energy

{}^{8}B

solar neutrino interactions, with recoil electron kinetic energies as low as

\sim 3.5 MeV

. Super-Kamiokande-IV data-taking began in September of 2008; this paper includes data until February 2014, a total livetime of 1664 days. The measured solar neutrino flux is

(2.308 \pm 0.020 {(stat)}_{- 0.040}^{+ 0.039} (syst)) \times 1 0^{6} / ({cm}^{2} \sec)

assuming no oscillations. The observed recoil electron energy spectrum is consistent with no distortions due to neutrino oscillations. An extended maximum likelihood fit to the amplitude of the expected solar zenith angle variation of the neutrino-electron elastic scattering rate in SK-IV results in a day/night asymmetry of

(- 3.6 \pm 1.6 (stat) \pm 0.6 (syst)) %

. The SK-IV solar neutrino data determine the solar mixing angle as

\sin^{2} θ_{12} = {0.327}_{- 0.031}^{+ 0.026}

, all SK solar data (SK-I, SK-II, SK III and SK-IV) measures this angle to be

\sin^{2} θ_{12} = {0.334}_{- 0.023}^{+ 0.027}

, the determined mass-squared splitting is

Δ m_{21}^{2} = {4.8}_{- 0.8}^{+ 1.5} \times 10^{- 5} {eV}^{2}

1 May 2015 in Progress of Theoretical and Experimental Physics

Journal Article

Physics potential of a long-baseline neutrino oscillation experiment using a J-PARC neutrino beam and Hyper-Kamiokande

Hyper-Kamiokande Proto-Collaboration

K. Abe

H. Aihara

C. Andreopoulos

I. Anghel

M. Zito

+243

Hyper-Kamiokande will be a next-generation underground water Cherenkov detector with a total (fiducial) mass of 0.99 (0.56) million metric tons, approximately 20 (25) times larger than that of Super-Kamiokande. One of the main goals of Hyper-Kamiokande is the study of $$CP$$ asymmetry in the lepton sector using accelerator neutrino and anti-neutrino beams. In this paper, the physics potential of a long-baseline neutrino experiment using the Hyper-Kamiokande detector and a neutrino beam from the J-PARC proton synchrotron is presented. The analysis uses the framework and systematic uncertainties derived from the ongoing T2K experiment. With a total exposure of 7.5 MW $$\times 10^7$$s integrated proton beam power (corresponding to $$1.56 \times 10^{22}$$ protons on target with a 30 GeV proton beam) to a $$2.5^\circ$$ off-axis neutrino beam, it is expected that the leptonic $$CP$$ phase $$\delta _{CP}$$ can be determined to better than 19 degrees for all possible values of $$\delta _{CP}$$, and $$CP$$ violation can be established with a statistical significance of more than $$3\,\sigma$$ ($$5\,\sigma$$) for $$76{\%}$$ ($$58{\%}$$) of the $${\delta _{CP}}$$ parameter space. Using both $$\nu _e$$ appearance and $$\nu _\mu$$ disappearance data, the expected 1$$\sigma$$ uncertainty of $$\sin ^2\theta _{23}$$ is 0.015(0.006) for $$\sin ^2\theta _{23}=0.5(0.45)$$.

1 January 2012 in Clinical Microbiology Reviews

Journal Article

Bed Bugs: Clinical Relevance and Control Options

Stephen Doggett

Dominic E. Dwyer

Pablo Fernandez-Peñas

Richard C. Russell

SUMMARY: Since the late 1990s, bed bugs of the speciesCimex lectulariusandCimex hemipterushave undergone a worldwide resurgence. These bed bugs are blood-sucking insects that readily bite humans. Cutaneous reactions may occur and can start out as small macular lesions that can develop into distinctive wheals of around 5 cm in diameter, which are accompanied by intense itching. Occasionally, bullous eruptions may result. If bed bugs are numerous, the patient can present with widespread urticaria or eythematous rashes. Often, bites occur in lines along the limbs. Over 40 pathogens have been detected in bed bugs, but there is no definitive evidence that they transmit any disease-causing organisms to humans. Anemia may result when bed bugs are numerous, and their allergens can trigger asthmatic reactions. The misuse of chemicals and other technologies for controlling bed bugs has the potential to have a deleterious impact on human health, while the insect itself can be the cause of significant psychological trauma. The control of bed bugs is challenging and should encompass a multidisciplinary approach utilizing nonchemical means of control and the judicious use of insecticides. For accommodation providers, risk management procedures should be implemented to reduce the potential of bed bug infestations.

About Me

Dr Ali Azimi received his PhD in non-melanoma skin cancer proteomics from the University of Sydney in 2019. Since then, he has been working as a post-doctoral cancer research associate with the Westmead Clinical School, Faculty of Medicine and Health, the University Sydney. Ali's primary research interest is to explore, optimize and implement innovative, next-generation proteomic workflows that enable the delivery of excellent science and impact in skin lesion diagnosis, classification and intervention. He has published several papers investigating and identifying the protein signatures of skin cancers using biopsy samples as well as patient samples collected non-invasively by tape stripping. Ali was awarded the Sydney West Transitional Cancer Research (SW-TCRC) Fellowship in 2019. Subsequently, he received the SW-TCRC Early Career Accelerator Grant in 2020. The award of these grants allowed him to expand the application of mass spectrometry-based proteomics to resolve the molecular landscape of metastatic melanoma and non-melanoma skin cancers. Driven by his current research findings, and in close collaboration with clinicians at Westmead and Royal Prince Alfred hospitals, Ali is interested in developing a novel tape-stripping approach for the identification, validation, and translation of biomarkers for a non-invasive diagnosis of skin cancers that would otherwise not be possible without invasive surgical interventions.

Prof. Dr. Pablo Fernandez-Peñas

Prof. Dr. Pablo Fernandez-Peñas

Research Focus & Metrics

Academic Career Length

Publication Type Breakdown

Representative Publications

About Me